bf/NASDAQ:MGTA_icon.jpeg

NASDAQ:MGTA

Dianthus Therapeutics, Inc.

  • Stock

0.70

−7.74%

−0.06

USD last updated 16/08 01:55:59

Last Close

0.76

11/09 20:00

Market Cap

42.44M

Beta: 2.08

Volume Today

375.91K

Avg: 596.90K

PE Ratio

−0.61

PFCF: −0.58

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and my...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -8-6-4-22017-03-312018-11-082020-03-032021-11-042023-06-26

    Revenue (Estimate*)

    0.000.000.010.010.012017-03-312018-11-082020-03-032021-11-042023-06-26

    *Estimate based on analyst consensus